Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome

ClinicalTrials.gov ID: NCT01077960

Public ClinicalTrials.gov record NCT01077960. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 12:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III, Multi-Center, Open, 12-Week, Follow-up Safety and Efficacy Study of Serostim® in Subjects With Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome (HARS)

Study identification

NCT ID
NCT01077960
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
EMD Serono
Industry
Enrollment
126 participants

Conditions and interventions

Interventions

  • Serostim Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2005
Primary completion
Dec 31, 2005
Completion
Dec 31, 2005
Last update posted
Aug 6, 2013

2005 – 2006

United States locations

U.S. sites
25
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
University of Alabama/Birmingham Birmingham Alabama
Care Clinic Los Angeles California
Private Practice Palm Beach California
UCSD - AVRC (AntiViralResearchCenter) San Diego California
Kaiser Permanente San Francisco California
Harbor-UCLA Medical Center Torrence California
AIDS Alliance West Hollywood California
Circle Medical LLC Norwalk Connecticut
Private Practice Washington D.C. District of Columbia
Private Practice Fort Lauderdale Florida
Care Resources Miami Florida
Private Practice Miami Florida
Private Practice North Miami Beach Florida
Infectious Disease Associates Sarasota Florida
AIDS Research Consortium of Atlanta Atlanta Georgia
Rush University Medical Center Chicago Illinois
Community Research Initiative of New England Boston Massachusetts
Tufts University School of Medicine Boston Massachusetts
Hennepin County Medical Center Minneapolis Minnesota
St. Luke's Roosevelt Hospital New York New York
St. Vincents Catholic Medical Center New York New York
Weill Medical College of Cornell University New York New York
Central Texas Clinical Research Austin Texas
IPD Research Annandale Virginia
Private Practice Spokane Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01077960, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2013 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01077960 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →